Hexagon Capital Partners’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-715
| Closed | -$22.3K | – | 1373 |
|
|
2025
Q1 | $22.3K | Buy |
715
+1
| +0.1% | +$31 | ﹤0.01% | 720 |
|
|
2024
Q4 | $18.2K | Buy |
714
+365
| +105% | +$9.31K | ﹤0.01% | 818 |
|
|
2024
Q3 | $9.87K | Buy |
349
+13
| +4% | +$368 | ﹤0.01% | 929 |
|
|
2024
Q2 | $8.86K | Sell |
336
-108
| -24% | -$2.85K | ﹤0.01% | 903 |
|
|
2024
Q1 | $13.5K | Sell |
444
-105
| -19% | -$3.19K | ﹤0.01% | 776 |
|
|
2023
Q4 | $15.4K | Sell |
549
-69
| -11% | -$1.94K | ﹤0.01% | 722 |
|
|
2023
Q3 | $16.8K | Buy |
+618
| New | +$16.8K | ﹤0.01% | 610 |
|
|
2022
Q4 | – | Sell |
-9
| Closed | – | – | 1507 |
|
|
2022
Q3 | $0 | Buy |
+9
| New | – | ﹤0.01% | 1414 |
|